Abstract | INTRODUCTION: METHODS: The effect of A-SAA on human embryonic kidney (HEK), TLR2 or TLR4 cells was quantified by nuclear factor (NF)-κB luciferase reporter assays. A-SAA-induced RASFC and dHMVEC function were performed in the presence of a specific neutralising anti-TLR2 mAb (OPN301) (1 μg/mL) and matched IgG isotype control Ab (1 μg/mL). Cell surface expression of intracellular adhesion molecule (ICAM)-1, chemokine expression, cell migration, invasion and angiogenesis were assessed by flow cytometry, ELISA, Matrigel invasion chambers and tube formation assays. MyD88 expression was assessed by real-time PCR and western blot. RESULTS: A-SAA induced TLR2 activation through induction of NF-κB (p<0.05), but failed to induce NF-κB in HEK-TLR4 cells, confirming specificity for TLR2. A-SAA-induced proliferation, invasion and migration were significantly inhibited in the presence of anti-TLR2 (all p<0.05), with no significant effect observed for tumour necrosis factor-α-induced events. Additionally, A-SAA-induced ICAM-1, interleukin-8, monocyte chemoattractant protein-1, RANTES and GRO-α expression were significantly reduced in the presence of anti-TLR2 (all p<0.05), as was A-SAA induced angiogenesis (p<0.05). Finally, A-SAA induced MyD88 signalling in RASFC and dHMVEC (p<0.05). CONCLUSIONS: A-SAA is an endogenous ligand for TLR2, inducing pro-inflammatory effects in RA. Blocking the A-SAA/TLR2 interaction may be a potential therapeutic intervention in RA.
|
Authors | Mary Connolly, Peter R Rooney, Trudy McGarry, Ashwini X Maratha, Jennifer McCormick, Sinead M Miggin, Douglas J Veale, Ursula Fearon |
Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 75
Issue 7
Pg. 1392-8
(07 2016)
ISSN: 1468-2060 [Electronic] England |
PMID | 26290589
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ |
Chemical References |
- Cytokines
- Ligands
- NF-kappa B
- Serum Amyloid A Protein
- Toll-Like Receptor 2
- Intercellular Adhesion Molecule-1
|
Topics |
- Acute Disease
- Arthritis, Rheumatoid
(blood, pathology)
- Cell Movement
- Cytokines
(blood)
- Humans
- Intercellular Adhesion Molecule-1
(metabolism)
- Ligands
- NF-kappa B
(metabolism)
- Neovascularization, Pathologic
- Serum Amyloid A Protein
(metabolism)
- Toll-Like Receptor 2
(blood)
|